I support everything the hon. Lady has just said. I was a research nurse in cancer care for more than 10 years. We observed good clinical practice standards, and the standards of the Medicines and Healthcare Products Regulatory Agency and the FDA, because mistakes happened. Those safeguards are in place for a reason. The No. 1 reason is to protect the patient.
Access to Medical Treatments (Innovation) Bill (Money)
Proceeding contribution from
Maria Caulfield
(Conservative)
in the House of Commons on Tuesday, 3 November 2015.
It occurred during Debate on bills on Access to Medical Treatments (Innovation) Bill (Money).
About this proceeding contribution
Reference
601 c930Session
2015-16Chamber / Committee
House of Commons chamberLibrarians' tools
Timestamp
2017-03-22 15:55:48 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2015-11-03/15110340000593
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2015-11-03/15110340000593
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2015-11-03/15110340000593